Neurocognitive tests
OtherCohort study: all parents and participants will have questionnaires to complete, based on participant's age.
Other names: Quality of life
NCT Number: NCT06124092
More than 10,000 children are hospitalized in an PICU every year in Canada. While most of them will survive their PICU hospitalization and their critical illness, some children will not recover to their pre-illness level. Some may develop behavioral, physical, emotional or developmental problems and difficulties at school. All these problems are elements that are part of the Pediatric Post-Intensive Care Syndrome (PICS-p).
It is important to understand the elements (risk factors) that play a role in the development of PICS-p. In Canada, there is no systematic follow-up for children after they leave the PICU. Understanding what can cause PICS-p (risk factors) and how much PICS-p has an impact on children and their family is very important to the family well-being.
Trial opening soon.
Get NotifiedUp to 18 year
All sexes
Observational
Alberta Children's Hospital, Calgary, Alberta, Canada
The Pediatric Post-Intensive Care Syndrome (PICS-p) is a newly developed conceptual framework that incorporates the constellation of morbidities that are increasingly recognized to affect children and their families after a critical illness. Experts define PICS-p as a new or worsening impairment in any of the following 5 domains of child health: physical, cognitive, emotional, social, or family.
In contrast to well established follow-up programs in adults, there is currently a lack of systematic follow-up of PICU survivors which prevents both the recognition and management of PICS-p. The absence of granular, empirical data on the recovery of PICU children impedes both the identification and management of PICS-p.
This project is a prospective Canadian multicenter cohort study to identify risk factors of PICS-p, develop and validate a predictive model for PICS-p to detect at-risk children, characterize each domain of PICS-p over two years post critical illness and uncover additional morbidities that are not captured using the current PICS-p framework. This study will provide granular, empirical data on which to build developmentally appropriate and tailored screening, management, and intervention programs during and after PICU to improve the global recovery of critically ill children and their family.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cohort study: all parents and participants will have questionnaires to complete, based on participant's age.
Other names: Quality of life
Time frame: 2 months after PICU discharge
Identification of modifiable and non-modifiable risk factors
Time frame: 2 months after PICU discharge
The model will allow detection at PICU discharge of children in need of post-PICU follow-up
Time frame: At 2 months, 12, 18 months and 36 months post PICU discharge
Identify which domain gets impacted and when during the course of the follow-up
Time frame: Until 36 months post PICU discharge
Detection of morbidities through the medical provider interview that are not included in the current framework.
Time frame: Until 36 months post PICU discharge
Descrie the variety of healthcare professional and medical required post PICU hospitalization.
Contact information is provided by the study sponsor or research team.
Geneviève Du Pont-Tibodeau, MD
CONTACT
514-345-4931 ext. 5553
Laurence Ducharme-Crevier, MD
CONTACT
514-345-4931 ext. 4118
St. Justine's Hospital
Other
After Pediatric Critical Illness (APCI)
Acronym: APCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03767517
Brain Diseases, Cancer
Alexander City, Alabama, United States
View Trial DetailsNCT04407182
COVID-19, Cardiopathy
Guayaquil, Ecuador
View Trial DetailsNCT03446794
Arrhythmias, Cardiac, Atrial Fibrillation
Torrevieja, Alicante, Spain
View Trial DetailsNCT03438123
Basal Ganglia Diseases, Bone Diseases
Caen, Normandy, France
View Trial Details